{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:48:44Z","timestamp":1788565724252,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10014-021-00421-2","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:03:33Z","timestamp":1641686613000},"page":"130-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors"],"prefix":"10.1007","volume":"39","author":[{"given":"Eita","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Shirahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Fujimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,9]]},"reference":[{"key":"421_CR1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.437996","author":"P Canning","year":"2013","unstructured":"Canning P, Cooper CDO, Krojer T et al (2013) Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M112.437996","journal-title":"J Biol Chem"},{"key":"421_CR2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.126","author":"SN Chi","year":"2004","unstructured":"Chi SN, Gardner SL, Levy AS et al (2004) Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2004.12.126","journal-title":"J Clin Oncol"},{"key":"421_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.10.128","author":"J Choque-Velasquez","year":"2019","unstructured":"Choque-Velasquez J, Resendiz-Nieves JC, Jahromi BR et al (2019) Pineal parenchymal tumors of intermediate differentiation: a long-term follow-up study in Helsinki neurosurgery. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2018.10.128","journal-title":"World Neurosurg"},{"key":"421_CR4","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.sup.2017-0001","author":"Committee of Brain Tumor Registry of Japan","year":"2017","unstructured":"Committee of Brain Tumor Registry of Japan (2017) Report of brain tumor registry of Japan (2005\u20132008). Neurol Med Chir (Tokyo). https:\/\/doi.org\/10.2176\/nmc.sup.2017-0001","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"421_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-01997-y","author":"L de Kock","year":"2020","unstructured":"de Kock L, Priest JR, Foulkes WD et al (2020) An update on the central nervous system manifestations of DICER1 syndrome. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-01997-y","journal-title":"Acta Neuropathol"},{"key":"421_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1318-7","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Druker H et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-014-1318-7","journal-title":"Acta Neuropathol"},{"key":"421_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov002","author":"E Duregon","year":"2015","unstructured":"Duregon E, Cassenti A, Pittaro A et al (2015) Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nov002","journal-title":"Neuro Oncol"},{"key":"421_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26373","author":"AJ Esbenshade","year":"2017","unstructured":"Esbenshade AJ, Kocak M, Hershon L et al (2017) A phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26373","journal-title":"Pediatr Blood Cancer"},{"key":"421_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(99)00389-2","author":"F Fauchon","year":"2000","unstructured":"Fauchon F, Jouvet A, Paquis P et al (2000) Parenchymal pineal tumors: a clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/s0360-3016(99)00389-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"421_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2011.01202.x","author":"M Fevre-Montange","year":"2012","unstructured":"Fevre-Montange M, Vasiljevic A, Frappaz D et al (2012) Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01202.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"421_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos292","author":"C Friedrich","year":"2013","unstructured":"Friedrich C, von Bueren AO, von Hoff K et al (2013) Treatment of young children with CNS-primitive neuroectodermal tumors\/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nos292","journal-title":"Neuro Oncol"},{"key":"421_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(06)70867-1","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D et al (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. https:\/\/doi.org\/10.1016\/s1470-2045(06)70867-1","journal-title":"Lancet Oncol"},{"key":"421_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.04.017","author":"NU Gerber","year":"2014","unstructured":"Gerber NU, von Hoff K, Resch A et al (2014) Treatment of children with central nervous system primitive neuroectodermal tumors\/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"421_CR14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.096","author":"S Gururangan","year":"2003","unstructured":"Gururangan S, McLaughlin C, Quinn J et al (2003) High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2003.10.096","journal-title":"J Clin Oncol"},{"key":"421_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2013.02.007","author":"T Ito","year":"2014","unstructured":"Ito T, Kanno H, Sato K et al (2014) Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2013.02.007","journal-title":"World Neurosurg"},{"key":"421_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25405","author":"RI Jakacki","year":"2015","unstructured":"Jakacki RI, Burger PC, Kocak M et al (2015) Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.25405","journal-title":"Pediatr Blood Cancer"},{"key":"421_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2000.tb00242.x","author":"A Jouvet","year":"2000","unstructured":"Jouvet A, Saint-Pierre G, Fauchon F et al (2000) Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol. https:\/\/doi.org\/10.1111\/j.1750-3639.2000.tb00242.x","journal-title":"Brain Pathol"},{"key":"421_CR18","first-page":"170","volume-title":"WHO classification of tumours of the central nervous system","author":"A Jouvet","year":"2016","unstructured":"Jouvet A, Vasiljevic A, Nakazato Y et al (2016) Tumours of the pineal region. In: Louis D (ed) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 170\u2013182","edition":"4"},{"key":"421_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"421_CR20","doi-asserted-by":"publisher","DOI":"10.1023\/a:1012773727022","author":"Y Korogi","year":"2001","unstructured":"Korogi Y, Takahashi M, Ushio Y (2001) MRI of pineal region tumors. J Neurooncol. https:\/\/doi.org\/10.1023\/a:1012773727022","journal-title":"J Neurooncol"},{"key":"421_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2018.01.027","author":"N Kumar","year":"2018","unstructured":"Kumar N, Srinivasa GY, Madan R et al (2018) Role of radiotherapy in residual pineal parenchymal tumors. Clin Neurol Neurosurg. https:\/\/doi.org\/10.1016\/j.clineuro.2018.01.027","journal-title":"Clin Neurol Neurosurg"},{"key":"421_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-01990-5","author":"JC Lee","year":"2019","unstructured":"Lee JC, Mazor T, Lao R et al (2019) Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-01990-5","journal-title":"Acta Neuropathol"},{"key":"421_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02111-y","author":"BK Li","year":"2020","unstructured":"Li BK, Vasiljevic A, Dufour C et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a rare brain tumor consortium registry study. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02111-y","journal-title":"Acta Neuropathol"},{"key":"421_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02106-9","author":"APY Liu","year":"2020","unstructured":"Liu APY, Gudenas B, Lin T et al (2020) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02106-9","journal-title":"Acta Neuropathol"},{"key":"421_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.10.025","author":"S Mallick","year":"2016","unstructured":"Mallick S, Benson R, Rath GK (2016) Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis. Radiother Oncol. https:\/\/doi.org\/10.1016\/j.radonc.2016.10.025","journal-title":"Radiother Oncol"},{"key":"421_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now234","author":"M Mynarek","year":"2017","unstructured":"Mynarek M, Pizer B, Dufour C et al (2017) Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US head start data. Neuro-Oncol. https:\/\/doi.org\/10.1093\/neuonc\/now234","journal-title":"Neuro-Oncol"},{"key":"421_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/nature22973","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature. https:\/\/doi.org\/10.1038\/nature22973","journal-title":"Nature"},{"key":"421_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyx005","author":"KA Parikh","year":"2017","unstructured":"Parikh KA, Venable GT, Orr BA et al (2017) Pineoblastoma-the experience at St. Jude Children\u2019s Research Hospital. Neurosurgery. https:\/\/doi.org\/10.1093\/neuros\/nyx005","journal-title":"Neurosurgery"},{"key":"421_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02101-0","author":"E Pfaff","year":"2020","unstructured":"Pfaff E, Aichmuller C, Sill M et al (2020) Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02101-0","journal-title":"Acta Neuropathol"},{"key":"421_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now105","author":"DR Raleigh","year":"2017","unstructured":"Raleigh DR, Solomon DA, Lloyd SA et al (2017) Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/now105","journal-title":"Neuro Oncol"},{"key":"421_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/BF02478904","author":"I Tsumanuma","year":"1999","unstructured":"Tsumanuma I, Tanaka R, Washiyama K (1999) Clinicopathological study of pineal parenchymal tumors: correlation between histopathological features, proliferative potential, and prognosis. Brain Tumor Pathol. https:\/\/doi.org\/10.1007\/BF02478904","journal-title":"Brain Tumor Pathol"},{"key":"421_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309805","author":"T Yu","year":"2016","unstructured":"Yu T, Sun X, Wang J et al (2016) Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2014-309805","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"421_CR33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7154","author":"P Zhu","year":"2016","unstructured":"Zhu P, Zhang CB, Yang P et al (2016) Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.7154","journal-title":"Oncotarget"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-021-00421-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T06:39:29Z","timestamp":1654670369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-021-00421-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1007\/s10014-021-00421-2","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,9]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}